Small-molecule pipeline stability
Empirical small-molecule formulation development targeting chronic metabolic and cardiovascular pathways. Engineered in Bangalore, documented for absolute international compliance.
Formulation stress testing
Thermal Stress
pH Profiling
Assay Purity
Formulations undergo rigorous accelerated thermal degradation testing at sixty degrees Celsius to guarantee long-term molecular stability under diverse global distribution conditions.
Precision pH-dependence mapping ensures optimal dissolution profiles across targeted metabolic pathways, eliminating systemic absorption variability during clinical phases.
High-performance liquid chromatography verifies active pharmaceutical ingredient purity exceeds ninety-nine percent, establishing an empirical baseline for international licensing dossiers.
Active development pipeline
Our current small-molecule formulations targeting primary chronic indications. All dossiers are fully prepared for international licensing.
SGLT2 Formulation
GLP-1 Co-Agonist
Optimized small-molecule formulation with enhanced bioavailability. Indicated for chronic heart failure management, this candidate delivers exceptional shelf-life stability.
Stable oral solid dosage form engineered for high gastric stability and sustained systemic release profiles, minimizing active ingredient degradation.
Phase I
Stability testing complete
Phase II
Dossier preparation active
Transparent compliance tracking
We deliver complete, audit-ready regulatory dossiers alongside every formulation license. Our Bangalore facility operates under strict real-time compliance tracking, ensuring seamless transition to international clinical trials.
Initiate licensing discussion
Connect with our Bangalore-based technical team to request regulatory dossiers, stability data, or sample batches for evaluation.